Market opportunities include the demand for training on EU Clinical Trial Regulation compliance, especially in mastering submissions and procedures for drugs and biologics. The course caters to ...

The main market opportunities lie in providing updated training and resources that focus on practical application and interpretation of evolving clinical research regulations, particularly for GCP, EU ...

In 2014, Regulation (EU) No. 536/2014, known as the new Clinical Trials Regulation, was adopted. The goal of the regulation is to provide faster, more coordinated assessments for clinical trial ...

Innovation is not just a luxury but a necessity in the realm of clinical trials, particularly as we strive to accelerate drug development. Yet, the slow pace of innovation within the U.S. clinical ...

The CTR came into effect in the EU on January 31st, 2023, to replace the EU Clinical Trials Directive (CTD) with a goal of harmonizing the submission and review of clinical trials in the EU and ...

Clinical trials are essential in bringing new, improved treatment options to patients. They support our hospitals, bringing ...

NEW YORK--(BUSINESS WIRE)--Massive Bio, which uses artificial intelligence and concierge service to match cancer patients to oncology clinical trials regardless of their location or financial ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced proposals to "streamline" clinical trial approvals, in what it called "the biggest overhaul of trial regulation in 20 years ...

DUBLIN--(BUSINESS WIRE)--The "EU (European Union) Clinical Trial Regulation 536/2014: Overview and Implementation Experience Training Course" conference has been added to ResearchAndMarkets.com's ...